Latest news and research on all cancers and treatments, updated several times a week
Just going for a stroll slashes the risk of recurrence by up to half
Elaine Frazer, from Lisburn in Northern Ireland, had breast cancer at 40
At the time she was 16st. At 5ft 10in her BMI was over 32 - officially obese
Now 45, she used every ounce of determination to slim down to 13st
A healthy lifestyle can have an effect 'comparable to drugs'
Walking a mile a day 'could cut the risk of cancer recurring by 40 per cent'
[Which is what I have been banging on about for 7 years now. I walk an average of 5 miles/day (about 10,000 steps)]
Opdivo and others in its class work by removing a brake that cancer puts on the immune system. In some patients, just removing the brake is enough ...
That molecule, present on many immune and cancer cells, is called ... “In many cases, as soon as you turn on the immune system to fight a tumor, you ...
That's one of more than 30 cancer types for which the drug, designated a ... They mobilize the body's immune system to "uncloak" and attack cancer ...
"It's the idea of teaching the immune system -- your own immune system -- to recognize, attack and clear cancer cells,” Washington University ...
AstraZeneca is to investigate the potential of cancer-killing viruses as part of a deal ... Oncolytic viruses are still a fairly nascent area of cancer research. ... result in an unusual collaboration between viruses and the immune system, ...
Madrid, Spain (Scicasts) — Notch genes are a double-edged sword: in some cancers they have a harmful effect because they promote tumour growth, ...
Long-term survival rates following laparoscopic surgery for bladder cancer are comparable to those of open surgery, according to a study published in ...
Abbott acquired exclusive rights for FGFR3 gene mutations for use in bladder cancer from Institut Curie. The FGFR3 biomarker can be used for early ...
... two vaccines and one drug each for Alzheimer's disease, hardening of the arteries, dust mite allergies, hepatitis C, osteoporosis and bladder cancer.
Enadenotucirev is also under investigation in two further European clinical studies in patients with colorectal cancer, bladder cancer, non-small cell ...
With "more than 40,000 new cases of prostate cancer and 11,000 of bladder cancer each year in the UK", the company believes current diagnostic ...
A team of researchers, led by scientists at Yale and the biotech company Genentech, have completed a phase I clinical trial for a new cancer ...
This is the first time a survival advantage over chemo has been shown in lungcancer with an immunotherapy-type drug, the company says.
Previous clinical trials have already demonstrated the safety and efficacy of thisimmunotherapy in ovarian cancer patients whose tumor had ...
The Roswell Park team, led by Dr. Kunle Odunsi, executive director of the Center for Immunotherapy, will take stem cells from the blood of cancer ...
Cancer News in Science Daily
A new protein-protein interaction that could serve as a target for future therapies for the most common form of brain cancer, glioblastoma multiforme (GBM), has been identified by researchers. GBM is a devastating disease that originates from glia or their precursors within the central nervous system, and the prognosis for GBM patients is unfortunately poor, but this discovery offers new therapeutic potential.
Clinical trial patients with metastatic colorectal cancer who had high levels of vitamin D in their bloodstream prior to treatment with chemotherapy and targeted drugs, survived longer, on average, than patients with lower levels of the vitamin, researchers report.
Breast cancer: Anthropometric and metabolic dowels integrate metabolic details and contribute to an increasingly complex puzzle
Once more, the multifactorial and heterogeneous nature of breast cancer fascinates researchers. In a new study, researchers have focused on a specific breast cancer subtype known as luminal B breast cancer, as well as its relationship with BMI, insulin and estrogen receptor (ER) expression.
The ancient physician/alchemist, Paracelsus, said: 'The dose makes the poison.' According to a new study, even oxygen may fall prey to the above adage. While essential to human life, aspects of oxygen metabolism may promote cancer. Capitalizing on the inverse relationship of oxygen concentration with elevation, researchers found lower rates of lung cancer at higher elevations, a trend that did not extend to non-respiratory cancers, suggesting that carcinogen exposure occurs via inhalation.
Bile duct cancers are amongst the most aggressive tumor-related diseases and, so far, the medical treatment options available have been limited. Clinical oncologists have now demonstrated that the substance nab-paclitaxel, a biochemically modified ingredient that occurs in the bark of the Pacific yew tree, could be highly effective against bile duct cancers.
Children of melanoma survivors are not adhering optimally to sun protection recommendations, researchers have discovered in a groundbreaking new study. This is concerning as sunburns are a major risk factor for melanoma, and children of survivors are at increased risk for developing the disease as adults.
Sunitinib, an agent approved for use in several cancers, provides unprecedented antitumor activity in thymic carcinoma, a rare but aggressive tumor of the thymus gland, according to a phase II clinical trial.
Tambahkan Komentar